From: Favorable SSTR subtype selectivity of SiTATE: new momentum for clinical [18F]SiTATE PET
Peptides | hsst1 | hsst2 | hsst3 | hsst4 | hsst5 |
---|---|---|---|---|---|
SST-28 | 5.2 ± 0.3 | 2.7 ± 0.3 | 7.7 ± 0.9 | 5.6 ± 0.4 | 4.0 ± 0.3 |
Octreotide | > 10.000 | 2.0 ± 0.7 | 187 ± 55 | > 1.000 | 22 ± 6 |
DOTA-TOC | > 10.000 | 14 ± 2.6 | 880 ± 324 | > 1.000 | 393 ± 84 |
Ga-DOTA-TOC | > 10.000 | 2.5 ± 0.5 | 613 ± 140 | > 1.000 | 73 ± 21 |
DOTA-[Tyr3]-octreotate | > 10.000 | 1.5 ± 0.4 | > 1.000 | 453 ± 176 | 547 ± 160 |
Ga-DOTA-[Tyr3]-octreotate | > 10.000 | 0.2 ± 0.04 | > 1.000 | 300 ± 140 | 377 ± 18 |
SiTATE | > 10.000 | 1.0 ± 0.2 | 712 ± 507 | 364 ± 291 | > 1.000 |